|•||Q1 2014 Press Release:||May 1, 2014 at 7:00 a.m. ET|
|•||Q1 2014 Conference Call:||May 1, 2014 at 8:30 a.m. ET|
|•||Domestic Dial-In Number:||877-407-8037|
|•||International Dial-In Number:||201-689-8037|
|•||Conference ID #||13580001|
'Blind side' competition is playing havoc with some highly visible companies, says Jim Cramer. You can't compete with free.
Jim Cramer's bullish on Alexion Pharmaceuticals and Incyte. But, he says, Disney's good for the long term.
Jim Cramer doesn't buy the backlash against Amazon. He says Prime is a very powerful tool and an irresistible bargain.
Jim Cramer is bullish on Citigroup, Zoetis, Idexx Labs, AbbVie, Nucor, and Alexion.